14:10:47 EDT Thu 28 Mar 2024
Enter Symbol
or Name
USA
CA



MYM Nutraceuticals Inc
Symbol MYM
Shares Issued 82,014,977
Close 2017-09-19 C$ 0.59
Market Cap C$ 48,388,836
Recent Sedar Documents

MYM Nutraceuticals hires Incanco as consultant

2017-09-19 09:41 ET - News Release

Mr. Rob Gietl reports

MYM ENTERS INTO CONSULTING AGREEMENT WITH LEADING CANNABIS INDUSTRY LEGAL EXPERTS - INTERNATIONAL CANNABIS CONSULTANTS CO.

MYM Nutraceuticals Inc. has entered into a consulting agreement with International Cannabis Consultants Co. (Incanco), a leading authority on the legal framework of cannabis legislation in Canada. Incanco's chief operating officer, John Conroy, has been a trailblazer in effecting groundbreaking legal changes to cannabis legislation in Canada for many years.

Under the consulting agreement, MYM engaged Incanco for a three-year consulting term, effective Sept. 18, 2017. Pursuant to the consulting agreement Incanco provides various consulting services, including, but not limited to, the following:

  1. Aid in navigating current and future regulatory regimes for cannabis and cannabis products;
  2. Helping to secure a licence for MYM to produce and distribute cannabis and cannabis products from its proposed facility in Weedon, Que.;
  3. Facilitate export licence for MYM to distribute cannabis and cannabis products outside of Canada -- primarily in the United States;
  4. Assist in submitting grants to the Quebec provincial government to further the completion of the project in Weedon, Que.;
  5. Introduce MYM to potential investors interested in financing current and future projects;
  6. Approach various levels of government to ensure that coming regulatory regime for legal cannabis includes extant dispensaries as the primary retail outlets for distribution of cannabis and cannabis products to the public.

Incanco's principal, Mr. Conroy, has extensive background as legal counsel in constitutional and criminal law cases with respect to cannabis legislation. Mr. Conroy acted as lead counsel in the legal proceeding of Allard versus Canada, which resulted in a successful constitutional challenge to the Marijuana for Medical Purposes Regulations that led to the current Access to Cannabis for Medical Purposes Regulations. As a result, medically approved patients are able to continue to produce cannabis for themselves or have a designated grower do so for them. Mr. Conroy is currently involved in communications with federal government officials in Ottawa at Health Canada, making submissions with respect to the proposed Cannabis Act anticipated to become law in July, 2018, and to legalize recreational marijuana. He recently appeared as a witness before the parliamentary standing committee on health that is studying Bill C-45 before it goes to third reading in Parliament and is anticipated to become law. In the near term, he expects to be consulting and making submissions with respect to British Columbia provincial legislation as well as engaging other provinces with respect to their proposed legislation.

"Engaging the legal expertise of Incanco in a consulting and advising capacity will help MYM execute the intricate process of securing its licences, both in Canada and for export into the United States," said Rob Gietl, chief executive officer of MYM. "Mr. Conroy is a distinguished expert on the constitutional and legal framework of cannabis in Canada and the United States through his membership in both the Canadian and U.S. National Organization for the Reform on Marijuana Laws (NOMRL) and, particularly, the U.S. NORML legal committee since the mid-1970s. Mr. Conroy will help MYM achieve its goal to become a global leader in the medicinal cannabis industry."

Under the terms of the consulting agreement, Incanco will receive 300,000 common shares in the capital of MYM at an issue price of 55 cents per share in satisfaction of a $165,000 signing bonus. Incanco will also be issued 150,000 common share purchase warrants, with each warrant entitling Incanco to acquire one common share in the capital of MYM for a period of 36 months from the warrant's grant date. The exercise price of each warrant is 55 cents.

About MYM Nutraceuticals Inc.

MYM is an innovative company focused on acquiring Health Canada licences to produce and sell high-end organic medicinal cannabis supplements and topical products. To ensure a strong presence and growth potential within the industry, MYM is actively looking to the acquire complementary businesses and assets in the technology, nutraceutical and CBD (cannabidiol) sectors.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.